Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0HZ2A
|
||||
Former ID |
DIB008833
|
||||
Drug Name |
Recombinant factor VIIa PEGylated liposomal
|
||||
Synonyms |
Recombinant factor VIIa; Recombinant factor VIIa (PEGylated liposomal (NecLip), Hemophilia A) Recoly
|
||||
Indication | Factor VII deficiency [ICD10:D68] | Phase 1/2 | [1] | ||
Company |
Recoly NV
|
||||
Target and Pathway | |||||
Target(s) | Coagulation factor VII | Target Info | Modulator | [2] | |
KEGG Pathway | Complement and coagulation cascades | ||||
PANTHER Pathway | Angiogenesis | ||||
Blood coagulation | |||||
PathWhiz Pathway | Coagulation | ||||
Reactome | BMAL1:CLOCK,NPAS2 activates circadian gene expression | ||||
Extrinsic Pathway of Fibrin Clot Formation | |||||
Gamma-carboxylation of protein precursors | |||||
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | |||||
Removal of aminoterminal propeptides from gamma-carboxylated proteins | |||||
WikiPathways | Complement and Coagulation Cascades | ||||
PTM: gamma carboxylation, hypusine formation and arylsulfatase activation | |||||
Blood Clotting Cascade | |||||
Formation of Fibrin Clot (Clotting Cascade) | |||||
Circadian Clock | |||||
Folate Metabolism | |||||
Vitamin B12 Metabolism | |||||
Selenium Micronutrient Network | |||||
References | |||||
REF 1 | Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII--an open label, exploratory, cross-over, phase I/II study. Haemophilia. 2010 Nov;16(6):910-8. | ||||
REF 2 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2363). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.